NANOFH.HE
SellHot AirNanoform Finland Oyj · Healthcare · Finland · $86M · Avg Vol: $68K/d
Hot Air: Rising on momentum alone: weak business, rich price.
ABOUT NANOFORM FINLAND OYJ
Read
Nanoform Finland Oyj is an innovative drug delivery technology company providing nanoparticle engineering services to the global pharmaceutical industry. The company utilizes its proprietary multi-patented CESS (Controlled Expansion of Supercritical Solutions) technology to improve the solubility and bioavailability of drug candidates. Its competitive advantage lies in this unique, scalable nanonization platform that addresses a major bottleneck in drug development.
FINANCIAL SUMMARY (EUR)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.5M | 2.6M | 2.8M | 3.5M | 0.6% | 5.6M | 5.2M | 8.2M | 52.5% |
| EPS (EUR) | -0.29 | -0.26 | -0.28 | -0.21 | — | -0.16 | -0.14 | -0.11 | — |
| Shares | 78.4M | 78.4M | 85.5M | 85.7M | +9.3% | 85.8M | — | — | — |
| Debt | 6.9M | 6.3M | 5.6M | 6.2M | -3.6% | 6.5M | — | — | — |
| Equity | 87.2M | 66.9M | 60.0M | 42.8M | -21.1% | — | — | — | — |
| Op CF | -20.1M | -18.0M | -18.3M | -17.7M | — | -13.6M | — | — | — |
| Inv CF | -9.6M | -35.5M | 27.4M | 5.1M | — | — | — | — | — |
| Fin CF | 22.7M | -1.2M | 13.6M | 0.1M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of NANOFH.HE are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| NANOFH.HE | Nanoform Finland Oyj(you) | $86M | 31 | Sell |
| FARN.L | Faron Pharmaceuticals Oy | $95M | 7 | Strong Sell |
| HRTIS.HE | Herantis Pharma Oyj | $51M | 5 | Strong Sell |
| NXTMH.HE | Nexstim Plc | $79M | 27 | Sell |
| MODU.HE | Modulight Oyj | $51M | 32 | Sell |
| OPTOMED.HE | Optomed Oyj | $59M | 16 | Strong Sell |
| HEALTH.HE | Nightingale Health Oyj | $65M | 13 | Strong Sell |
| AIFORIA.HE | Aiforia Technologies Oyj | $74M | 3 | Strong Sell |
| REG1V.HE | Revenio Group Oyj | $435M | 44 | Hold |
| ORIOLA.HE | Oriola Oyj | $191M | 67 | Buy |
Peer medians: ROE -4.3% · P/E 19.5x · Gross margin 65.9%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.